Device Trial Radar · NCT07917208
Early Feasibility Study of the Capstan Medical TMVR System
Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
15
Planned (sponsor's estimate)
Start
Nov 2026
Primary completion
Apr 2027
Study completion Mar 2032
Sponsor
- Lead sponsor
- Capstan MedicalNot on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 4, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This early feasibility study is evaluating the safety and performance of the Capstan Compass Robotic System™ for transcatheter mitral valve replacement in patients with symptomatic, moderate-to-severe or severe mitral regurgitation who are unsuitable for surgical repair or transcatheter edge-to-edge repair.
Conditions
- Mitral Regurgitation (MR)
Interventions
Capstan Compass Robotic System for Transcatheter Mitral Valve ReplacementDevice
Capstan System includes the Capstan Mitral Valve
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Safety EndpointTime frame: 30 Days
- Primary Performance EndpointTime frame: At the end of the procedure
- Primary Performance EndpointTime frame: At the end of the procedure
4 more outcomes with a free account
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Kaiser Permanente
San Francisco, California · Not yet recruiting
The Christ Hospital
Cincinnati, Ohio · Recruiting
Vanderbilt University Medical Center
Nashville, Tennessee · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.